Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)
Titel:
Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)
Auteur:
Gogas, Helen Dummer, Reinhard Ascierto, Paolo A. Arance, Ana Mandalà, Mario Liszkay, Gabriella Garbe, Claus Schadendorf, Dirk Krajsová, Ivana Gutzmer, Ralf Sileni, Vanna Chiarion Dutriaux, Caroline Yamazaki, Naoya Loquai, Carmen Queirolo, Paola Jan de Willem, Groot Sellier, Abir Tadmouri Suissa, Jeanne Murris, Juliette Gollerkeri, Ashwin Robert, Caroline Flaherty, Keith T.